111 Inc (YI)
1.27
-0.06
(-4.15%)
USD |
NASDAQ |
May 21, 15:07
111 Total Assets (Quarterly): 435.78M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 435.78M |
September 30, 2023 | 460.64M |
June 30, 2023 | 420.49M |
March 31, 2023 | 470.63M |
December 31, 2022 | 503.50M |
September 30, 2022 | 428.71M |
June 30, 2022 | 463.15M |
March 31, 2022 | 473.66M |
December 31, 2021 | 493.53M |
September 30, 2021 | 483.86M |
June 30, 2021 | 510.44M |
March 31, 2021 | 467.84M |
Date | Value |
---|---|
December 31, 2020 | 463.24M |
September 30, 2020 | 398.60M |
June 30, 2020 | 265.91M |
March 31, 2020 | 231.88M |
December 31, 2019 | 230.15M |
September 30, 2019 | 234.99M |
June 30, 2019 | 252.52M |
March 31, 2019 | 238.98M |
December 31, 2018 | 224.80M |
September 30, 2018 | 246.30M |
June 30, 2018 | 161.84M |
December 31, 2017 | 116.93M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
230.15M
Minimum
Dec 2019
510.44M
Maximum
Jun 2021
404.71M
Average
460.64M
Median
Sep 2023
Total Assets (Quarterly) Benchmarks
Concord Medical Services Holdings Ltd | 854.04M |
Sinovac Biotech Ltd | 13.66B |
CASI Pharmaceuticals Inc | 58.01M |
Zai Lab Ltd | 988.44M |
ASLAN Pharmaceuticals Ltd | 20.99M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 396.83M |
Shareholders Equity (Quarterly) | -82.31M |
Debt to Equity Ratio | -0.5794 |
Current Ratio | 1.069 |
Net Debt Paydown Yield | -2.33% |